Clinical Trial Update: Extension Study for Patients Who Have Participated in a BMN 701 Study [Phase 2]

View source ↗

Summary

Extension study of BMN 701 in Pompe disease participants from a prior BMN 701 trial (Phase 2) has been terminated; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pompe Disease

Drugs mentioned

• BMN 701

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Pompe Disease | Phase 2 | Status: TERMINATED | Results posted: 2018-05-22